These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20390357)

  • 1. Aggression in borderline personality disorder.
    Látalová K; Prasko J
    Psychiatr Q; 2010 Sep; 81(3):239-51. PubMed ID: 20390357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences and similarities in aggression, suicidal behaviour, and psychiatric comorbidity in borderline personality disorder.
    Sher L; Rutter SB; New AS; Siever LJ; Hazlett EA
    Acta Psychiatr Scand; 2019 Feb; 139(2):145-153. PubMed ID: 30353921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulsive aggression in borderline personality disorder.
    Goodman M; New A
    Curr Psychiatry Rep; 2000 Feb; 2(1):56-61. PubMed ID: 11122933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive behavior and self-harm in Borderline Personality Disorder: The role of impulsivity and emotion dysregulation in a sample of outpatients.
    Terzi L; Martino F; Berardi D; Bortolotti B; Sasdelli A; Menchetti M
    Psychiatry Res; 2017 Mar; 249():321-326. PubMed ID: 28152466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of borderline personality disorder with risperidone.
    Rocca P; Marchiaro L; Cocuzza E; Bogetto F
    J Clin Psychiatry; 2002 Mar; 63(3):241-4. PubMed ID: 11926724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.
    Aguglia A; Mineo L; Rodolico A; Signorelli MS; Aguglia E
    Int Clin Psychopharmacol; 2018 May; 33(3):121-130. PubMed ID: 29189421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A relationship between bipolar II disorder and borderline personality disorder?
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1022-9. PubMed ID: 18313825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affective and Behavioral Characteristics of Adolescent and Adult Borderline Personality Disorder.
    Cardona ND; Temes CM; Magni LR; Hein KE; Aguirre BA; Goodman M; Zanarini MC
    J Pers Disord; 2021 Jun; 35(Suppl B):131-141. PubMed ID: 33779284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline personality disorder and bipolar disorder comorbidity in suicidal patients: diagnostic and therapeutic challenges.
    Marcinko D; Vuksan-Cusa B
    Psychiatr Danub; 2009 Sep; 21(3):386-90. PubMed ID: 19794362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacologic treatment of borderline personality disorder.
    Ripoll LH
    Dialogues Clin Neurosci; 2013 Jun; 15(2):213-24. PubMed ID: 24174895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulsiveness, impulsive aggression, personality disorder, and spousal violence.
    Edwards DW; Scott CL; Yarvis RM; Paizis CL; Panizzon MS
    Violence Vict; 2003 Feb; 18(1):3-14. PubMed ID: 12733616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Linehan MM; McDavid JD; Brown MZ; Sayrs JH; Gallop RJ
    J Clin Psychiatry; 2008 Jun; 69(6):999-1005. PubMed ID: 18466045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Symptom-focussed drug therapy in borderline personality disorder].
    Schmahl C; Bohus M
    Fortschr Neurol Psychiatr; 2001 Jul; 69(7):310-21. PubMed ID: 11488246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the suicidal behavior of adolescent inpatients with borderline personality disorder and major depression.
    Horesh N; Orbach I; Gothelf D; Efrati M; Apter A
    J Nerv Ment Dis; 2003 Sep; 191(9):582-8. PubMed ID: 14504567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline Personality Disorder: A Review.
    Leichsenring F; Heim N; Leweke F; Spitzer C; Steinert C; Kernberg OF
    JAMA; 2023 Feb; 329(8):670-679. PubMed ID: 36853245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggression in borderline personality disorder: evidence for increased risk and clinical predictors.
    Allen A; Links PS
    Curr Psychiatry Rep; 2012 Feb; 14(1):62-9. PubMed ID: 22033830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression.
    McGirr A; Paris J; Lesage A; Renaud J; Turecki G
    J Clin Psychiatry; 2007 May; 68(5):721-9. PubMed ID: 17503981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.
    Simeon D; Baker B; Chaplin W; Braun A; Hollander E
    CNS Spectr; 2007 Jun; 12(6):439-43. PubMed ID: 17545954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.